Menu

Earnings Update by AlphaStreet
Analysis

Ashland Narrows Fiscal 2026 EBITDA Guidance Following First-Quarter Loss

The specialty ingredients manufacturer lowered the top end of its annual profit outlook citing operational delays and weather disruptions. First-quarter results showed declining sales across most segments, partially offset by resilient demand in pharmaceutical applications and improved cash flow generation. Ashland Inc. (NYSE: ASH) reported a net loss for the first quarter of fiscal 2026 […]
Advertisement
Latest Earnings Call Transcripts View All →

Interviews & CEO Insights

View All →

Subscribe to AlphaStreet

Get the latest market insights delivered to your inbox.

Latest Market Analysis











Top